What You Should Know:
- Affidea, a pan-European provider of community-based polyclinics, specialist services, and advanced diagnostics, has announced a strategic collaboration with b-rayZ, a leader in AI-powered breast imaging solutions.
- The strategic partnership aims to revolutionize breast cancer diagnostics by streamlining the patient pathway, enhancing precision, and improving therapeutic options for women across Europe.
Enhancing Clinical Precision and Patient
Read More
Breast Cancer
AI Shows Promise in Detecting Overlooked Breast Cancers Between Screenings, UCLA Study Reveals
What You Should Know:
- Artificial intelligence (AI) could play a crucial role in identifying breast cancers that develop between routine screening mammograms, potentially detecting them before they become more advanced and challenging to treat, according to a new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.
- The research suggests that integrating AI into breast cancer screening practices could lead to earlier treatment and improved
Read More
iCAD to Integrate AI Breast Cancer Detection into Microsoft’s Precision Imaging Network
What You Should Know:
- iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced today a strategic collaboration with Microsoft.
- The partnership will integrate a set of iCAD's AI-powered mammography solutions, part of its ProFound Breast Health Suite, into Microsoft’s Precision Imaging Network, significantly expanding access to advanced breast cancer detection tools for clinicians.
Integrating AI Mammography into Leading Radiology
Read More
SimonMed Imaging Partners with Lunit to Deploy AI for Breast Cancer Detection
What You Should Know:
- SimonMed Imaging, one of the largest and most advanced outpatient medical imaging providers in the United States, announced a significant partnership with Lunit, a global leader in AI-driven cancer diagnostics and therapeutics.
- The collaboration aims to bring a new era of artificial intelligence (AI)-powered breast cancer detection to patients across SimonMed's extensive network, marking a major milestone in the company's mission to save lives through
Read More
RadNet to Acquire iCAD for $103M in All-Stock Transaction
What You Should Know:
- RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, and iCAD, Inc., a global leader in AI-powered breast health solutions, announced that they have entered into a definitive merger agreement.
- Under the agreement, RadNet will acquire iCAD for $103M in an all-stock transaction.
Financial Details
Based on RadNet’s closing price on Monday, April 14, 2025, the transaction
Read More
GE HealthCare Launches AI-Powered Ultrasound for Enhanced Breast Cancer Detection in Dense Breasts
What You Should Know:
- GE HealthCare has unveiled Invenia™ Automated Breast Ultrasound (ABUS) Premium, a cutting-edge 3D ultrasound system designed to revolutionize breast cancer screening for women with dense breast tissue.
- The technology integrates artificial intelligence (AI) and innovative features to expedite supplemental screening, streamline exam readings, and improve detection accuracy.
AI-Driven 3D Breast Ultrasound
Dense breast tissue, present in a
Read More
iCAD, RamSoft Integrate to Enhance AI Breast Cancer Detection
What You Should Know:
- iCAD, Inc., a global leader in AI-powered cancer detection solutions, and RamSoft®, a provider of cloud-based radiology solutions announced a strategic partnership to integrate iCAD's ProFound AI® Breast Health Suite into RamSoft's PowerServer platform.
- The collaboration will bring advanced AI capabilities to imaging centers and healthcare providers across the US and Canada, enhancing breast cancer detection and improving patient care.
Addressing
Read More
SimonMed Imaging Launches AI-Powered Personalized Breast Cancer Detection Program
What You Should Know:
- SimonMed Imaging, a provider of outpatient medical imaging services in the United States, today announced the nationwide launch of its AI-enabled Personalized Breast Cancer Detection (PBCD) program.
- The program offers women a more comprehensive and personalized approach to breast cancer screening, empowering them to make informed decisions about their health.
PBCD Program Costs
For a cost of $40, patients can add the PBCD program to their
Read More
ScreenPoint Medical Acquires Biomediq to Enhance Breast Cancer Risk Assessment with AI
What You Should Know:
- ScreenPoint Medical, a provider of AI-powered breast cancer screening solutions, acquires Biomediq A/S, a research-based company specializing in quantitative imaging biomarkers. Financial details of the acquisition were not disclosed.
- ScreenPoint's industry-leading Transpara AI platform will now incorporate Biomediq's advanced risk analysis technology, which enables automated analysis of 2D and 3D mammograms to assess future breast cancer risk. This
Read More
GE HealthCare Unveils Mammography System to Improve Patient-Centered Breast Care
What You Should Know:
- GE HealthCare has announced the launch of its new Pristina Via™ mammography system, designed to improve the screening experience for both technologists and patients. This innovative system, debuting at the Radiological Society of North America's 2024 Annual Meeting, addresses the growing need for efficient workflows and personalized care in breast imaging.
- GE HealthCare developed Pristina Via™ based on extensive feedback from mammography technologists. The company
Read More
